What Is Regenerative Stem Cell Biotherapy?

Regenerative stem cell biotherapy is an innovative, promising method in modern medicine. Autologous (the patient's own) multipotent mesenchymal stem cells (MMSCs) from adipose tissue and bone marrow, as well as allogeneic (donor) hematopoietic stem cells (HSCs) from umbilical cord blood and placental tissue, can serve as an effective regenerative (restorative, healing) factor.

Every person's body contains stem cells. However, administering them in doses millions of times greater than their normal levels in the body makes it possible to restore the myelin sheath of damaged nerve fibers and curb the excessive immune response that often causes this kind of damage.

The potential of using stem cells to treat central nervous system conditions rests on their core property — differentiation potential. Upon receiving a neural signal of damage to a part of the body, the brain directs a portion of the stem cells to the so-called "lesion site," where they transform into cells of the damaged brain tissue, replacing the diseased ones.

In other words, stem cells can independently locate the source of damage and the cause of organ or system dysfunction. They migrate to the site of the lesion and trigger a whole cascade of regenerative reactions there, restoring impaired functions. This makes it possible to use stem cell biotherapy to help patients with conditions whose exact cause remains unknown to modern science.
Using regenerative stem cell biotherapy methods helps stimulate the repair of tissues and impaired organ function, stabilizes the condition for a certain period, benefits vascular and nerve tissue, and helps maintain adequate immune system function as part of a comprehensive restorative and supportive treatment plan.

The primary goal of regenerative stem cell biotherapy is to stop or slow disease progression and preserve the patient's quality of life. To achieve the best possible results, we design a personalized stem cell treatment program tailored to the patient's needs. The effectiveness of stem cell biotherapy depends on the disease stage, age, presence of co-occurring conditions, and other factors. Treatment outcomes can range from halting disease progression to lasting improvement or even full remission. Stem cell treatment is indicated when previously prescribed medications and physiotherapy haven't produced results. However, combining stem cell biotherapy with traditional treatment methods is also extremely effective. That's why regenerative stem cell biotherapy can help patients with even the most severe conditions.

We have a successful 10-year track record researching the use of stem cells to treat a wide range of conditions. Based on this experience, our specialists have concluded that the greatest effect is achieved using autologous (the patient's own) and allogeneic (donor) stem cells, either separately or in combination with each other.

Stem cell biotherapy eliminates the risk of immunological mismatch and adverse reactions such as rejection or cell mutation, whether using the patient's own cells or allogeneic (donor) cells. If there are contraindications to using the patient's own stem cells (for example, if the patient's condition makes collecting biomaterial impossible), donor cells from certified biobanks can be used successfully instead.